Sofosbuvir-ribavirin combo shows promise for hepatitis C

04/24/2013 | HealthDay News

A study in the New England Journal of Medicine found that combining hepatitis C treatment sofosbuvir with ribavirin for patients who cannot take interferon led to a 78% cure rate after three months of treatment. In patients unresponsive to interferon, the study observed a 73% cure rate after four months of treatment with the two-drug combo. Another study found cure rates of 67% for treatment with either sofosbuvir and ribavirin, or ribavirin and interferon.

View Full Article in:

HealthDay News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Healthcare Compliance Manager
Ernst & Young
Multiple Locations, SL_Multiple Locations
Executive Vice President-MyHealth First Network
Greenville Health System
Greenville, SC
Director, Health Plan Administration, Payor Relations and Contracting
St. Charles Health System
Bend, OR
Chief Medical Officer
VANDERBILT HEALTH AFFILIATE NETWORK
Nashville, TN
Director, Health Plan Administration, Payor Relations and Contracting
St. Charles Health System
Bend, OR